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Objective: To assess the association between food com-
bination and Alzheimer disease (AD) risk. Because foods
are not consumed in isolation, dietary pattern (DP) analy-
sis of food combination, taking into account the inter-
actions among food components, may offer methodologi-
cal advantages.
Design: Prospective cohort study.
Setting: Northern Manhattan, New York, New York.
Patients or Other Participants: Two thousand one
hundred forty-eight community-based elderly subjects
(aged 65 years) without dementia in New York pro-
vided dietary information and were prospectively evalu-
ated with the same standardized neurological and neu-
ropsychological measures approximately every 1.5 years.
Using reduced rank regression, we calculated DPs based
on their ability to explain variation in 7 potentially AD-
related nutrients: saturated fatty acids, monounsatu-
rated fatty acids,-3 polyunsaturated fatty acids,-6 poly-
unsaturated fatty acids, vitamin E, vitamin B12, and folate.
The associations of reduced rank regression–derived DPs
with AD risk were then examined using a Cox propor-
tional hazards model.
Main Outcome Measure: Incident AD risk.
Results: Two hundred fifty-three subjects developed AD
during a follow-up of 3.9 years. We identified a DP
strongly associated with lower AD risk: compared with
subjects in the lowest tertile of adherence to this pat-
tern, the AD hazard ratio (95% confidence interval) for
subjects in the highest DP tertile was 0.62 (0.43-0.89)
after multivariable adjustment (P for trend=.01). This DP
was characterized by higher intakes of salad dressing, nuts,
fish, tomatoes, poultry, cruciferous vegetables, fruits, and
dark and green leafy vegetables and a lower intake of high-
fat dairy products, red meat, organ meat, and butter.
Conclusion: Simultaneous consideration of previous
knowledge regarding potentially AD-related nutrients and
multiple food groups can aid in identifying food combi-
nations that are associated with AD risk.
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E PIDEMIOLOGICAL EVIDENCElinking diet, one of the mostimportant modifiable envi-ronmental factors, and riskof AD is rapidly increasing.
However, current literature regarding the
impact of individual nutrients or food
items on AD risk is inconsistent, partly
because humans eat meals with complex
combinations of nutrients or food items
that are likely to be synergistic.1 As an al-
ternative approach, dietary pattern (DP)
analysis has emerged in recent years.1,2
One type of approach to derive DPs is
a hypothesis-driven, or a priori, ap-
proach, which requires prior knowledge
of diet and diseases and uses existing scores
to indicate a DP. Two cross-sectional stud-
ies have used this approach to derive DPs
that were linked to cognitive function.3,4
Another example is the Mediterranean diet
(MeDi), higher adherence to which we
found to be related to a lower risk for AD
in the Washington Heights–Inwood Co-
lumbia Aging Project (WHICAP) popu-
lation.5-8 However, there are a few limita-
tions with the MeDi approach: (1) The
MeDi does not take advantage of accumu-
lating knowledge on the relation be-
tween nutrients and neurodegeneration.
(2) Only a limited number of foods (9 food
groups) are considered in the MeDi.
(3) The multiethnic population of the
WHICAP study may not strictly con-
sume foods typical of the Mediterranean
countries, and the “MeDi adherence” of
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our study population may therefore be significantly lower
as compared with Mediterranean populations.
The second type of DP-deriving approach is explor-
atory, or a posteriori, in nature. It uses statistical methods
such as principal component analysis to derive DPs. A few
cross-sectional studies have applied this approach to ex-
amine the associations between DPs and cognitive func-
tion.9,10 However, DPs identified by this approach may not
be the best predictors of disease risk,2 because this ap-
proach is entirely empirical, ignoring key nutrients that are
likely to be implied in the physiopathology.
A third option to derive DPs is reduced rank regres-
sion (RRR),11 which combines the a priori approach by
using prior information of nutrients-disease association
existing in the literature and the a posteriori approach
by using study-specific data.11 Since biologic knowledge
concerning development of a disease is based on the
role of nutrients rather than that of foods, DPs derived
by using RRR should better clarify the importance of
diet in the etiology of diseases than an approach such as
the MeDi one. Previous studies have successfully identi-
fied RRR-derived DPs that were strongly associated
with risks of various diseases, such as diabetes melli-
tus,12 coronary heart disease,11,13-19 and cancers.20,21 Nev-
ertheless, to our knowledge, the method has yet to be
applied in the neurology field.
In the current study, we aimed to identify a combi-
nation of foods that may relate to AD risk by applying
RRR in dietary data from 2148 elderly subjects without




The study included participants of 2 related cohorts recruited
in 1992 (WHICAP 1992) and 1999 (WHICAP 1999) who were
identified from a probability sample of Medicare beneficiaries
residing in northern Manhattan, New York.5-8,22 At entry, a phy-
sician elicited each subject’s medical and neurological histo-
ries and conducted standardized physical and neurological
examinations. Each subject also underwent a structured in-
person interview including an assessment of health and func-
tion and a neuropsychological battery.23 A global summary score
on the Clinical Dementia Rating (CDR)24 was assigned. Sub-
jects were followed up at intervals of approximately 1.5 years,
repeating the baseline examination and consensus diagnosis.5-8
ALZHEIMER DISEASE DIAGNOSIS
A consensus diagnosis for the presence or absence of dementia
was made at a diagnostic conference attended by neurologists
and neuropsychologists, using the neuropsychological battery
of tests and evidence of cognitive deficit (based on the neuro-
psychological scores as described earlier), evidence of impair-
ment in social or occupational function (as assessed by the Blessed
Dementia Rating Scale, the Schwab and England Activities of Daily
Living Scale, and the physician’s assessment), and evidence of
cognitive and social/occupational function decline as compared
with the past, as required by theDiagnostic and StatisticalManual
of Mental Disorders (Third Edition Revised).
The type of dementia was subsequently determined. For the
diagnosis of probable or possible Alzheimer disease (AD), the
criteria of the National Institute of Neurological and Commu-
nicative Disorders and Stroke–Alzheimer Disease and Related
Disorders Association25 were used. Since, according to the cri-
teria, stroke does not preclude the diagnosis of AD (unless cere-
brovascular disease is considered the primary cause of the de-
mentia), the diagnosis of AD with concomitant stroke was also
assigned. Therefore, dementia cases with cerebrovascular dam-
age could be classified either in the non-AD dementia cat-
egory or in the AD category.
Dietary data were not available to the consensus panel and
were not considered in the diagnostic process.
DIET DATA
Average food consumption over the year before the baseline
assessment was obtained using a 61-item version of the Wil-
lett semiquantitative food frequency questionnaire (SFFQ)
(Channing Laboratory, Cambridge, Massachusetts). Trained in-
terviewers administered the SFFQ in English or Spanish. The
SFFQs have been used and validated for the determination of
nutrient intake in the elderly26 and WHICAP22 populations. The
61 food items were categorized into 30 food groups based on
similarities in food and nutrient composition, and intake (grams
per day) of each food group was then calculated by summing
the intakes of member food items (eTable 1, http://www
.archneurol.com). The daily intake of nutrients was com-
puted by multiplying the consumption frequency of each por-
tion of every food by the nutrient content of the specified
portion.27 The nutrient intakes from foods and from supple-
ments were separately estimated, and only the nutrient intake
from foods was used in the RRR analysis.
COVARIATES EVALUATION
Information about recruitment cohort, age, sex, education, eth-
nicity, body mass index (BMI) (calculated as weight in kilo-
grams divided by height in meters squared), and smoking sta-
tus was obtained from baseline interviews. Caloric intake and
alcohol consumption were calculated from the baseline SFFQ.
Apolipoprotein E (APOE) ε4 genotype was used as a dichoto-
mous variable: absence vs presence (of either 1 or 2) of ε4 alleles.
A modified version5 of the Charlson Comorbidity Index28 (here-
after referred to as the “comorbidity index”) included items for
myocardial infarction, congestive heart failure, peripheral vas-
cular disease, hypertension, chronic obstructive pulmonary dis-
ease, arthritis, gastrointestinal disease, mild liver disease, dia-
betes, chronic renal disease, and systemic malignancy from the
initial visit. All items received weights of 1, with the exception
of chronic renal disease and systemic malignancy, which were
weighted 2. The index was treated as a continuous variable.
STATISTICAL ANALYSIS
Reduced Rank Regression
Reduced rank regression determines linear combinations, ie,
DP scores, of a set of predicting variables (food groups) by maxi-
mizing the explained variation of a set of response variables (nu-
trients) (eFigure 1).11 In this study, RRR was performed using
30 predetermined food groups (eTable 1) as predicting vari-
ables and 7 nutrients, saturated fatty acids (SFA), monounsat-
urated fatty acids,-3 polyunsaturated fatty acids (PUFA),-6
PUFA, vitamin E, vitamin B12, and folate, as response vari-
ables. The 7 nutrients are most consistently reported to be re-
lated to dementia risk according to the literature. Current evi-
dence suggests that an increase of dietary intake of SFA or total
fats could have negative effects on cognitive functions,29,30 while
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increased intake of PUFA30,31 and monounsaturated fatty ac-
ids30,31 may be protective against cognitive decline. Higher in-
takes of vitamin B12,32-35 folate,32-35 and vitamin E36-39 may be
related to better cognitive functioning or lower risk of AD in
elderly individuals. Both food group and nutrient intakes were
adjusted for caloric intake using the regression residual method,40
and their residuals were used in the analysis. Using an alter-
native method of total caloric intake adjustment (ie, Density
Model: food group intakes divided by total caloric intake [grams
per kilocalories]), did not change our results (data not shown).
For each subject, 7 DP scores, representing 7 mutually uncor-
related DPs, were obtained.11 A higher DP score indicates a stron-
ger adherence of a subject’s diet to the particular DP.
Survival Analyses
To evaluate the association between the extracted DPs and risk
of AD, we ran Cox models with AD as the dichotomous out-
come, time to event as the time metric, and each of the 7 DP
scores as the main predicting variable. The time-to-event vari-
able was time from recording of baseline diet to first visit of
AD diagnosis for incident cases or to the time of the last fol-
low-up for noncases. The following variables were adjusted: re-
cruitment cohort, age, sex, ethnicity, education, smoking sta-
tus, BMI, caloric intake, comorbidity index, and APOE ε4
genotype. Effect modification by these covariates was tested by
including an interaction term into the Cox models. All vari-
ables were used as time-constant covariates.
Supplementary Analyses
Current evidence suggests that moderate alcohol drinking may
be protective against incident dementia or delay age-
associated cognitive decline.22 Additionally, nutrient levels are
also affected by subjects’ intake of supplements. We therefore
adjusted for alcohol drinking or supplements intake of nutri-
ents to control confounding effects by these factors.
Among 2148 subjects without dementia (CDR0.5)41 at
baseline, 312 (15%) had a CDR of 0.5, which may be an index
of early subclinical disease. To increase our confidence that the
degree of adherence to DPs was not affected by the early sub-
clinical dementia process, we performed analysis by exclud-
ing subjects who were followed up for less than 2 years and
adjusting for baseline CDR status.
To overcome the limitation of the subjectiveness of nutri-
ents selection and to test the robustness of the results, we per-
formed RRR analyses by including into the model vitamin C,
-carotene, or both and obtained 3 sets of new DPs. The re-
sulting 3 sets of DPs were then compared with the original set
of 7 DPs from the original model with 7 nutrients. These 2 nu-
trients were associated with risk of AD as suggested in the lit-
erature,36,38,39,42,43 although not always consistently.44-46
In other exploratory models, we repeated the analyses ex-
cluding subjects who were diagnosed as having AD with con-
comitant stroke (ie, using only AD without stroke as the out-
come). We also repeated the analyses including probable AD
cases only.
Stability of RRR-Derived DP Scores
We used generalized estimating equations, with the DP scores
as the dependent variable and time (in years) as the predictor,
to test whether there were significant changes of RRR-derived
DP scores over time for a subset of subjects with more than 1
dietary assessment.5 We assessed the stability of RRR-derived
DP scores separately for incident cases and for subjects who
remained without dementia.
The RRR analyses were performed with SAS 9.1 (SAS Insti-
tute Inc, Cary, North Carolina) and all the other analyses were
performed using SPSS 12.0 (SPSS Inc, Chicago, Illinois).
RESULTS
PARTICIPANT CHARACTERISTICS
A total of 3436 among the initial 4166 subjects were
dementia-free at baseline. Because the dietary assess-
ment was added after initiation of the study, dietary
information was missing for 527 subjects.5 An addi-
tional 627 subjects were excluded because follow-up
was not available for them, among which 101 subjects
died within 1.5 years from baseline visit and 526 sub-
jects were lost to follow-up.5 Also excluded were 102
subjects who had incomplete dietary information pro-
hibiting calculation of RRR-derived DP scores and 32
subjects who developed dementia other than AD during
the follow-up period. Thus, the analytic sample com-
prised 2148 subjects.
Compared with subjects remaining in the final analy-
sis (N=2148), subjects with missing follow-up data
(n=526) were slightly younger (76.2 vs 77.2 years;
P=.004), less likely to be smokers (9.1% vs 12.5%;P=.03),
and less likely to be moderate alcohol drinkers (25.7%
vs 32.3%; P=.003) and had lower education (9.6 vs 10.0
years; P=.04), higher caloric intake (1488.4 vs 1426.3
kcal/d; P=.02), and higher BMI (28.0 vs 27.3; P=.03).
After an average follow-up of 3.96 years (SD, 3.0 years;
range, 0.14-13.9 years), 253 incident cases of AD were
identified. Compared with subjects who remained with-
out dementia, incident AD cases were older (P .001),
were less educated (P .001), had a lower BMI (P=.01),
were more likely to be Hispanic and less likely to be white
(P .001), and were less likely to be moderate alcohol
drinkers (P .001) (eTable 2).
DP SCORES AND RISK OF AD
The 7 DP scores, taken together, explained 76.8% and
29.5% of the total variation in nutrients and foods in-
takes, respectively (Table 1). The crude hazard ratios
(95% confidence interval;P trend) for subjects in the high-
est tertile compared with those in the lowest tertile for
DP scores 1 through 7, respectively, were as follows: 1.06
(0.78-1.45; .68), 0.54 (0.39-0.75; .001), 1.10 (0.81-
1.47; .58), 1.26 (0.94-1.70; .13), 1.16 (0.86-1.57; .34),
0.94 (0.69-1.27; .66), and 0.96 (0.72-1.29; .82).
Our subsequent analyses focused on DP score 2, the only
DP that was significantly associated with AD risk. The DP
score 2 was normally distributed with mean (SD) of 0.001
(1.06). A high DP score 2 reflected a diet rich in-3 PUFA,
-6 PUFA, vitamin E, and folate (positively correlated,
P .001), but poor in SFA and vitamin B12 (negatively cor-
related, P .001) (Table 1). The DP score 2 was positively
correlated with intakes of salad dressing, nuts, fish, toma-
toes, poultry, cruciferous vegetables, fruits, and dark and
green leafy vegetables (factor loadings 0.15) and nega-
tively correlated with intakes of high-fat dairy, red meat,
organ meat, and butter (factor loadings−0.15) (eTable 3).
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Subjects who were older, less educated, and current smok-
ers tended to adhere less to DP 2. Hispanic individuals ad-
hered less than white and black individuals to DP 2 (P=.02).
Women tended to adhere more than men to DP 2 (P=.05)
(Table 2).
The association between DP 2 and AD risk (model 1,
Table 3) (Figure) was essentially unchanged after ad-
justment for demographic factors including recruit-
ment cohort, age, education, ethnicity, and sex in a sec-
ond model (model 2, Table 3). Additional adjustment for
smoking status, BMI, caloric intake, comorbidity index,
and APOE ε4 genotype (model 3) only slightly attenu-
ated the AD risk: compared with subjects in the lowest
DP score 2 tertile, subjects in the middle and highest ter-
tiles, respectively, had 19% and 38% less risk for AD (P
trend=.01) (Table 3). No effect modification by any co-
variate was found.
SUPPLEMENTARY ANALYSES
Adding alcohol, nutrient supplements, or both in model
2 did not materially change the associations (Table 3).
Table 1. Explained Variations of Nutrients and Food Groups by Extracted DPs and Correlations Between Nutrients and DP Scores
Nutrients DP 1 DP 2 DP 3 DP 4 DP 5 DP 6 DP 7 Total
Explained % of Variation in Nutrients and Food Groups
SFA 47.87 19.37 1.56 4.98 6.51 0.02 1.56 81.87
MUFA 70.62 0.59 1.91 7.97 1.69 0.00 2.39 85.18
-3 PUFA 9.27 36.34 1.96 5.09 13.11 0.08 0.48 66.33
-6 PUFA 23.07 48.75 1.26 0.11 3.34 2.53 1.10 80.16
Vitamin E 0.03 13.85 1.51 2.36 1.06 10.16 0.22 29.18
Vitamin B12 0.17 6.05 84.92 6.53 0.71 0.00 0.00 98.39
Folate 52.14 5.30 13.24 23.81 1.61 0.62 0.04 96.76
Explained proportion of variation of all nutrients 29.02 18.61 15.20 7.26 4.00 1.91 0.83 76.84
Explained proportion of variation of all food groups 6.20 5.17 4.02 3.58 3.34 3.95 3.26 29.52
Pearson Correlation Coefficients Between Nutrients and Extracted DPs
SFA 0.69a −0.44a 0.12a 0.22a 0.26a 0.01 0.12a
MUFA 0.84a −0.08 0.14a 0.28a −0.13a 0.00 −0.15a
-3 PUFA 0.30a 0.60a 0.14a −0.23a 0.36a 0.03 −0.07
-6 PUFA 0.48a 0.70a 0.11a 0.03 −0.18a −0.16a 0.11a
Vitamin E 0.02 0.37a 0.12a 0.15a −0.10a 0.32a 0.05
Vitamin B12 −0.04 −0.25a 0.92a −0.26a −0.08a 0.00 0.01
Folate −0.72a 0.23a 0.36a 0.49a 0.13a −0.08 −0.02
Abbreviations: DP, dietary pattern; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids.
aP .001.










Cut points of DP score 2 −3.71 to −0.39 −0.39 to 0.36 0.37 to 16.3
Age at entry, y, mean (SD) 77.2 (6.6) 77.4 (6.7) 77.6 (6.6) 76.5 (6.3) .02
Female 1457 (68) 485 (65) 497 (69) 475 (70) .05
Education, y, mean (SD) 10.0 (4.8) 9.5 (4.7) 9.8 (4.6) 10.8 (4.8) .001
Ethnicity
White 596 (28) 200 (27) 188 (26) 208 (31) .02
Black 693 (32) 218 (29) 252 (35) 223 (33)
Hispanic 823 (38) 320 (43) 266 (37) 237 (35)
Other 36 (2) 11 (2) 11 (2) 14 (2)
Presence of APOE ε4 allele 508 (27) 193 (29) 174 (28) 141 (25) .07
Current smoker 268 (13) 122 (16) 79 (11) 67 (10) .001
Comorbidity index, mean (SD) 1.9 (1.4) 1.83 (1.4) 1.99 (1.4) 1.96 (1.5) .09
Caloric intake, kcal/d, mean (SD) 1426 (515) 1495 (523) 1320 (492) 1460 (512) .14
BMI, mean (SD) 27.4 (5.5) 27.1 (5.3) 27.5 (5.8) 27.5 (5.4) .23
Moderate alcohol drinking 693 (32) 244 (33) 209 (29) 240 (35) .35
Incident AD cases 253 (12) 117 (16) 86 (12) 50 (7) .001
Abbreviations: AD, Alzheimer disease; APOE, apolipoprotein E; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared);
DP, dietary pattern.
aThe tertiles were defined based on the distribution of the DP score 2 among participants who remained without dementia during the follow-up.
bP values for trend from logistic regression for binary variables and from linear regression models for continuous variables, with tertiles of the DP score
entering the models as an ordinal variable. P value for the categorical variable (ie, ethnicity) was from 2 test.
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Limiting analysis to the 1758 subjects with more than 2
years of follow-up, and adjusting baseline CDR in addi-
tion to all the covariates in model 2, the hazard ratios
(95% confidence interval; P value) for the middle and
highest tertiles were respectively 0.66 (0.48-0.91; .01) and
0.64 (0.44-0.92; .02) (P trend=.007) compared with the
lowest tertile (Table 3).
In RRR analysis considering additional nutrients,
we were able to extract additional 3 DPs that were
similar to DP 2 in terms of characterization of food
consumption as well as the associations with AD risk
(eTable 4). None of the other extracted DPs was signifi-
cantly associated with the risk of AD in any of the mod-
els (data not shown).
We repeated the analyses considering only 215 AD
cases without concomitant stroke (ie, excluding AD with
coexisting stroke, n=38). The results were essentially un-
changed. In a model adjusted for recruitment cohort, age,
education, ethnicity, and sex, compared with subjects in
the lowest tertile of DP score 2, AD hazard ratios (95%
confidence interval) for subjects in the middle and high-
est DP score 2 tertiles were 0.76 (0.56-1.03) and 0.58
(0.40-0.84), respectively (P for trend=.003). None of the
other DPs were significantly associated with AD risk (data
not shown).
When limiting analysis to probable AD only (a total
of 184 patients), after adjusting for recruitment cohort,
age, education, ethnicity, and sex, compared with sub-
jects in the lowest tertile of adherence to this pattern, the
probable AD hazard ratios (95% confidence interval) for
subjects in the middle and highest DP tertiles were 0.68
(0.48-0.97) and 0.64 (0.44-0.95), respectively (P for
trend=.02).





Tertileb HR (95% CI) P Value P Trendc
Model 1 253/2148 Lowest 1 [Reference]
Middle 0.73 (0.56-0.97) .03
Highest 0.54 (0.39-0.75) .001 .001
Model 2 251/2141 Lowest 1 [Reference]
Middle 0.72 (0.54-0.95) .02
Highest 0.59 (0.42-0.82) .002 .001
Model 3 211/1691 Lowest 1 [Reference]
Middle 0.81 (0.59-1.12) .20
Highest 0.62 (0.43-0.89) .01 .01
Supplementary Analysis
Model 2 and alcohol 251/2141 Lowest 1 [Reference]
Middle 0.70 (0.52-0.93) .01
Highest 0.59 (0.42-0.82) .002 .002
Model 2 and nutrient supplements 251/2141 Lowest 1 [Reference]
Middle 0.72 (0.54-0.96) .03
Highest 0.60 (0.43-0.85) .003 .002
Model 2 and alcohol and nutrient supplements 251/2141 Lowest 1 [Reference]
Middle 0.70 (0.53-0.93) .02
Highest 0.60 (0.43-0.85) .003 .002
Model 2 and baseline CDRd 204/1758 Lowest 1 [Reference]
Middle 0.66 (0.48-0.91) .01
Highest 0.64 (0.44-0.92) .02 .007
Abbreviations: AD, Alzheimer disease; CI, confidence interval; CDR, Clinical Dementia Rating; DP, dietary pattern; HR, hazard ratio.
aModel 1: unadjusted. Model 2: adjusted for recruitment cohort, age, education, ethnicity, and sex. Model 3: adjusted for covariates in model 2 and smoking
status, body mass index, caloric intake, comorbidity index, and APOE ε4 genotype.
bThe tertiles were defined based on the distribution of the DP score 2 among participants who remained without dementia during the follow-up.
cP trend was obtained by entering the tertile terms as an ordinal variable in the Cox model.
dLimited to subjects with more than 2 years of follow-up.




















Figure. Survival curves based on Cox analysis comparing cumulative
Alzheimer disease incidence in subjects belonging to each dietary pattern (DP)
score 2 tertile (P for trend.001). Lowest tertile (black line) corresponds to
the lowest adherence to DP 2; median tertile (dark-gray line), to median
adherence; and highest tertile (light-gray line), to the highest adherence. The
Figure was derived from a crude model that used all subjects (N=2148).
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DP SCORE 2 STABILITY
There were 1104 subjects with 2 or more dietary assess-
ments who remained without dementia during follow-
up. The mean interval between the first and second avail-
able dietary assessments was 5.3 years (SD, 2.1 years;
range, 1.0-15.4 years). The DP score 2 did not change
over time (=−0.02; P=.11).
There were 120 subjects with 2 or more dietary as-
sessments who developed incident AD during follow-
up. The mean interval between the first and second avail-
able dietary assessments was 6.8 years (SD, 2.8 years;
range, 1.8-15.5 years). The DP score 2 did not change
over time (=−0.02; P=.41).
COMMENT
In this prospective study, we identified a DP that ex-
plained variation of AD-related nutrients and was strongly
protective against the development of AD, even after con-
trolling for multiple covariates. This DP reflected a diet
rich in -3 PUFA, -6 PUFA, vitamin E, and folate, but
with lower SFA and vitamin B12. Furthermore, dietary hab-
its of subjects adhering more to this DP were character-
ized as high intake of salad dressing, nuts, fish, toma-
toes, poultry, cruciferous vegetables, fruits, and dark and
green leafy vegetables and low intake of high-fat dairy,
red meat, organ meat, and butter.
We previously reported that higher adherence to
the MeDi was associated with reduced risk of AD in
this WHICAP population.5,6 However, this multiethnic
population may not strictly consume foods typical of
the ones consumed in Mediterranean countries.
Hence, one goal of the present study was to see
whether there are “naturally existing” DPs in our
population that may also be associated with AD risk.
Interestingly, the identified protective DP 2 was very
similar to the MeDi,5-7,47 and they are correlated with
each other (Pearson r=0.35; P .001). Nevertheless,
from another point of view, this means only about
12% of DP 2’s variance was shared by the MeDi, indi-
cating that despite some overlap, important new infor-
mation was obtained in the current study. For
example, rather than treating each food group equally
in MeDi, the factor loadings of food–DP 2 help to
identify the relative importance of each food group,
thus providing more specific information.
Certain clarifications are needed in interpreting the re-
sults of the RRR method. Despite the fact that DP 1 ex-
plained most of the variation of nutrients, it was not asso-
ciated with risk of AD. Previous literature shows that it is
not always the DP that explains most of the variance that
is predictive of disease risk.11 In addition, the null associa-
tion of DP 1 with AD might be due to the fact that DP 1
was positively correlated with both SFA and monounsat-
urated fatty acids, which might have opposite effects on AD
risk. As a result, higher adherence to DP 1 might result in
consumption of nutrients with opposing effects regarding
the outcome. These results also indicated that a high or low
intake of a single food/nutrient might reveal little informa-
tion without taking into account other foods/nutrients. An-
other example is the low intake of vitamin B12 in the pro-
tective DP 2, which might lead to an interpretation of
vitamin B12 as an independent risk factor for AD. How-
ever, source foods of vitamin B12 like meat and dairy prod-
ucts may also contain a high level of SFA, which is a po-
tential AD risk factor.30 In addition, DP 2 only explained a
very small proportion (6.05%) of variation in vitamin B12.
Therefore, DPs potentially important for disease risk may
not be the ones that explain most of the variance of a single
nutrient but the ones that represent the optimal combina-
tion of nutrients (ie, simultaneous higher and lower quan-
tities of various nutrients that might offer the optimal bio-
logical synergy in relation to disease risk). In fact, all these
results reinforce the importance of studying DPs rather than
individual foods or nutrients. The DP analysis is prefer-
able also because of some of its advantages over the analy-
sis of single nutrients or food items. The effect of a single
nutrient or food item may be too small to detect. Indeed,
none of the nutrients was significantly associated with AD
risk in a fully adjusted model (data not shown). Or, a sta-
tistically significant association might be simply found by
chance alone because of multiple comparisons of many nu-
trients/foods or the interactions among them.2
The AD risk reduction role played by DP 2 is in gen-
eral in the expected direction as suggested by the associa-
tions between AD risk and these individual nutrients,29-39
except for vitamin B12. Furthermore, the selected 7 nutri-
ents (SFA, monounsaturated fatty acids, -3 PUFA, -6
PUFA, vitamin E, vitamin B12, and folate) reflected mul-
tiple pathways in the pathogenesis of AD. For example,
vitamin B12 and folate are homocysteine-related vitamins
that may have an impact on AD via their ability of reduc-
ing circulating homocysteine levels,48 vitamin E might pre-
vent AD via its strong antioxidant effect,48 and fatty acids
may be related to dementia and cognitive function through
atherosclerosis, thrombosis, or inflammation via an effect
on brain development and membrane functioning or via
accumulation of-amyloid.49 Thus, DP 2, reflecting a diet
rich in -3 PUFA, -6 PUFA, vitamin E, and folate, but
poor in SFA and vitamin B12, may have the protective effect
on AD involving all these pathways.
Our study has several limitations. First, we used a
single measurement of the diet, which might not cap-
ture the long-term diet habit of the subjects. However,
our analysis showed that DP 2 was quite stable over a
period of nearly 6 years. Second, excluding subjects
from the final analysis because of loss to follow-up or
missing data might have introduced selection bias.
Third, although DP 2 was still associated with a
reduced risk of AD after controlling for multiple socio-
economic factors, we could not completely rule out the
possibility of this association being due to residual con-
founding. Finally, the associations between DP 2 and
incident AD did not change materially after adjusting
for CDR at baseline and excluding subjects with a short
period of follow-up, but bias due to preclinical disease
cannot be completely excluded.
Our study has many advantages. Dietary data were col-
lected using a previously validated instrument.22 The pro-
spective study design reduces the possibility of recall bias.
The diagnosis of AD was based on comprehensive clini-
cal and neuropsychological assessment and standard re-
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search criteria. Measures for multiple potential AD risk
factors have been carefully recorded and adjusted for in
the analyses. The study participants were followed up at
relatively short intervals.
In conclusion, we identified a DP that was strongly
protective against the development of AD. The results of
the current study indicate that higher consumption of
certain foods (salad dressing, nuts, fish, tomatoes, poul-
try, cruciferous vegetables, fruits, dark and green leafy
vegetables) and lower of others (high-fat dairy, red meat,
organ meat, and butter) may be associated with a de-
creased risk of developing AD via a more favorable pro-
file of nutrients (ie, lower ingestion of SFA and higher
ingestion of PUFA, vitamin E, and folate). Our findings
provide support for further exploration of food combi-
nation–based dietary behavior for the prevention of this
important public health problem.
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Correction
Error in Tables and Text. In the article “Effects of Intensive Medical Therapy on Microemboli and Cardiovascular Risk in
Asymptomatic Carotid Stenosis” published in the February 2010 issue of the Archives (2010;67[2]:180-186), several data
values in Table 1 and Table 2were incorrect. The corrected tables are printed below. On page 183, in the fourth line of the
right-hand column, the total homocysteine concentration values were therefore also incorrect. The corrected sentence should
have read: “Plasma total homocysteine concentration was significantly higher among patients with microemboli (mean [SD],
15.61 [9.42] vs 10.16 [4.53] µmol/L).”
Table 1. Baseline Characteristics of Patients With





Age, y 69.82 (9.02) 68.30 (8.24) .32
SBP, mm Hg 147.90 (24.06) 147.85 (17.33) .99
DBP, mm Hg 79.87 (11.33) 81.92 (12.76) .51
Total plaque area, cm2 2.66 (1.54) 3.23 (1.26) .03
Carotid stenosis %b 94.71 (37.14) 106.50 (38.59) .35
C-reactive protein, mg/L 6.45 (20.73) 4.98 (4.18) .72
Total cholesterol, mg/dL 170 (41) 183 (39) .09
Triglycerides, mg/dL 150 (120) 169 (101) .35
HDL cholesterol, mg/dL 51 (18) 49 (15) .57
LDL cholesterol, mg/dL 91 (36) 99 (35) .22
Cholesterol to HDL ratio 3.62 (1.41) 3.97 (1.31) .15
Total homocysteine,
µmol/L
10.16 (4.53) 15.61 (9.42) .001
Serum vitamin B12, pg/mL 501 (268) 770 (461) .02
Smoking, pack-years 24.32 (24.87) 29.42 (29.80) .33
Female sex, % 37.1 40.5 .43
Smokers, % 18.10 43.2 .001
Diabetes, % 17.9 24.3 .38
Angina, % 32.3 35.1 .72
Claudication, % 16.2 32.4 .02
SBP130 mm Hg, % 16.9 15.4 .62




Cholesterol to HDL ratio
3.5, %
55.2 36.1 .04
Intracranial stenosis, % 23.2 45.9 .005
Abbreviations: DBP, diastolic blood pressure; HDL, high-density
lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood
pressure.
SI conversion factors: To convert C-reactive protein to
nanomoles per liter, multiply by 9.524; HDL, LDL, and total
cholesterol to millimoles per liter, multiply by 0.0259; triglycerides
to millimoles per liter, multiply by 0.0113; and vitamin B12 to
picomoles per liter, multiply by 0.7378.
aFor continuous variables, analysis of variance was used,
contrasting patients with and without microemboli. For categorical
variables, the Fisher exact test was used (2-sided).
bSum of the left and right internal carotid artery.
Table 2. Baseline Characteristics of Patients With
Asymptomatic Carotid Stenosis by Time
of Study Enrollment
Characteristic
Mean (SD) by Enrollment
P
ValueaBefore 2003 Since 2003
Age, y 70.11 (8.98) 69.39 (8.96) .39
SBP, mm Hg 154.73 (23.39) 145.79 (23.47) .01
DBP, mm Hg 82.75 (11.52) 79.02 (11.24) .66
Total plaque area, cm2 2.48 (1.29) 2.86 (1.65) .008
Carotid stenosis %b 97.43 (36.28) 88.0 (44.80) .46
C-reactive protein, mg/L 6.79 (20.15) 5.73 (19.36) .66
Total cholesterol, mg/dL 179 (36) 166 (44) .001
Triglycerides, mg/dL 165 (153) 141 (84) .03
HDL cholesterol, mg/dL 52 (19) 50 (18) .37
LDL cholesterol, mg/dL 94 (37) 90 (36) .18
Cholesterol to HDL ratio 3.73 (1.32) 3.59 (1.47) .31
Total homocysteine,
µmol/L
11.28 (6.45) 10.07 (4.10) .02
Serum vitamin B12, pg/mL 675 (422) 485 (242) .004
Smoking, pack-years 20.37 (24.22) 28.48 (25.70) .005
Female sex, % 42.2 33.8 .04
Smokers, % 18.1 21.6 .001
Diabetes, % 18.6 18.2 .51
Angina, % 33.2 32.0 .43
Claudication, % 25.1 11.9 .001
SBP130 mm Hg, % 10.7 18.7 .22




Cholesterol to HDL ratio
3.5, %
50.8 55.8 .17
Intracranial stenosis, % 36.2 16.7 .001
Abbreviations: DBP, diastolic blood pressure; HDL, high-density
lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood
pressure.
SI conversion factors: To convert C-reactive protein to nano-
moles per liter, multiply by 9.524; HDL, LDL, and total cholesterol to
millimoles per liter, multiply by 0.0259; triglycerides to millimoles
per liter, multiply by 0.0113; and vitamin B12 to picomoles per liter,
multiply by 0.7378.
aFor continuous variables, analysis of variance was used, con-
trasting patients with and without microemboli. For categorical vari-
ables, the Fisher exact test was used (2-sided).
bSum of the left and right internal carotid artery.
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